Fig. 3

Clinical features and a new nomogram as well as immunological characteristics. a Clinical correlation analysis in different risk groups of TCGA-KIRC [T (Tumor), N (Node), M (Metastasis)]. b ROC curves analysis of risk score and clinical information in TCGA-KIRC cohort. c ROC curves of OS in TCGA-KIRC cohort at 3 year, 5 years, and 7 years. d The nomogram to predict 1-, 3-, and 5-year OS in TCGA-KIRC cohort based on risk scores and clinical factors. e The Calibration chart for the evaluation of nomogram accuracy. f Differences of risk scores between the stable disease (SD), and progressive disease (PD) as well as complete response (CR) and partial response (PR) in the antiPD-L1/PD-1 overall response. g The violin plot for TIDE score in different risk groups. h The comparison of immune scores in different risk groups. i Role of the risk score in the immune function of TCGA-KIRC cohort. j The comparison of several immune signatures in different risk groups